It has long been recognized that the care of patients with PH requires organized and structured programs with defined goals. Established and accredited programs such as those that provide care for patients with cystic fibrosis or organ transplantation have demonstrated advantages that have resulted in standardized and ultimately improved specialized patient care. Therefore, in 2011, the Scientific Leadership Council (SLC) of the Pulmonary Hypertension Association (PHA) recommended the development of a nationwide accreditation program for PH centers. The PHA is now focusing on the accreditation of PH centers along with improving disease awareness and patients’ access to care. Two committees, the PHCC Oversight Committee (OC) and the PHCC Review Committee (RC), were established to carry out the administrative functions of the PHCC accreditation program. The OC comprises physicians, allied health professionals, a patient, a member of the board of trustees, an attorney, and PHA staff members. The OC is charged with analyzing and updating the PHCC accreditation criteria, program evaluation tools, and the accreditation scoring system. The OC is also responsible for establishing and governing the PHCC RC and reports to the PHA Board of Trustees. The OC currently comprises seven selected members, with each serving a 3-year term. The RC consists of 22 members including physicians and allied health professionals serving 2-year terms, supported by PHA PHCC staff. The responsibilities of the RC include reviewing site applications, conducting site visits, and determining accreditation status. This initiative resulted in a two-center system: pulmonary hypertension centers of comprehensive care and regional clinical programs. The SLC of the PHA stipulated that a PHCC, along with providing expert clinical care, should also develop basic and clinical research expertise and educate the next generation of providers.